(redirected from graft-versus-host disease)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to graft-versus-host disease: cGVHD
References in periodicals archive ?
Scope - The Graft-Versus-Host Disease (GVHD) EpiCast Report provides an overview of the risk factors, comorbidities, and the global and historical trends for the diagnosed incidence of hematopoietic stem cell transplantations (HSCTs) (including first, multiple, and re-transplants), segmented by transplant type (autologous and allogeneic), and the diagnosed incident cases of GVHD in the six major markets (6MM) (US, France, Germany, Italy, Spain, and UK).
Activated eosinophils in upper gastrointestinal tract of patients with graft-versus-host disease.
Graft-versus-host disease in lung transplantation: 4 case reports and literature review.
By increasing the overall success rate of an allogeneic bone marrow transplant while reducing the risk of graft-versus-host disease, our platform technology has the potential to lower the risk of infections, bleeding, and death in critically ill patients with haematologic malignancies following chemotherapy," said Mesoblast Chief Executive Professor Silviu Itescu.
Table 13: Selected drugs available for use in the prophylaxis of acute graft-versus-host disease 38
Adoptive Immunotherapy With Tregs Prevents Graft-Versus-Host Disease and Favors Immune Reconstitution After HLA Haploidentical Transplants for Hematological Malignancies
On the other hand, both studies show that mismatched cord-blood transplants are less apt to spawn acute attacks of graft-versus-host disease than mismatched marrow is.
The patent contains 39 claims relating to the composition and methods for treating graft-versus-host disease (GvHD) and, more specifically, to the administration of inhibitors of adenosine deaminase (ADA).
All the babies experienced some graft-versus-host disease, in which immune cells in the cord blood attack the recipient.
Dual targeting of Bruton's tyrosine kinase and Janus kinase 3 with rationally designed inhibitors prevents graft-versus-host disease (GVHD) in a murine allogeneic bone marrow transplantation model.